Bicycle Therapeutics Plc. (BCYC) NASDAQ

$17.16 0.16 (0.94%)

Market Cap: $508.77M

As of 06/29/22 04:00 PM EDT. Market closed.

(BCYC)

Bicycle Therapeutics Plc. (BCYC) NASDAQ

$17.16 0.16 (0.94%)

Market Cap: $508.77M

As of 06/29/22 04:00 PM EDT. Market closed.

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity ... read more

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle's lead product candidate, BT1718, a Bicycle Toxin Conjugate (BTC) that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial in collaboration with the Centre for Drug Development of Cancer Research UK. Bicycle is also evaluating BT5528, a second-generation BTC targeting EphA2, in a company-sponsored Phase I/II trial. BT8009 is a BTC targeting Nectin-4, a well-validated tumor antigen, and is also currently being evaluated in a Company-sponsored Phase I/II trial. Bicycle is headquartered in Cambridge, UK with many key functions and members of its leadership team located in Lexington, MA. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Kevin Lee
Full Time Employees
2,020
URL
Address
Babraham Hall, B900, Cambridgeshire, Cambridge, CB22 3AT.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Kevin Lee
Full Time Employees
2,020
Address
Babraham Hall, B900, Cambridgeshire, Cambridge, CB22 3AT.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$16.64
Previous Close
$17
Days Range
$16.61 - $17.70
52 week range
$12.08 - $62.08
Volume
146,458
Avg. Volume (30 days)
420,899
Market Cap
$508.77M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
29,648,534
Open
$16.64
Previous Close
$17
Days Range
$16.61 - $17.70
52 week range
$12.08 - $62.08
Volume
146,458
Avg. Volume (30 days)
420,899
Market Cap
$508.77M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
29,648,534

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BICYCLE THERAPEUTICS PLC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Milnes Alistair Chief Operating Officer Mar 25, 2022 Option Exercise $20.12 5,155 103,719 22,480 Mar 29, 2022, 04:36 PM
Keen Nicholas Chief Scientific Officer Dec 21, 2021 Option Exercise $14.00 15,477 216,678 15,477 Dec 22, 2021, 09:01 PM
Legault Pierre Director Dec 22, 2021 Option Exercise $8.48 97,860 829,853 97,860 Dec 22, 2021, 09:00 PM
Legault Pierre Director Dec 21, 2021 Option Exercise $8.44 44,537 375,892 44,537 Dec 22, 2021, 09:00 PM
Legault Pierre Director Dec 20, 2021 Option Exercise $8.41 7,603 63,941 7,603 Dec 22, 2021, 09:00 PM
Legault Pierre Director Dec 21, 2021 Sale $57.11 44,537 2,543,508 0 Dec 22, 2021, 09:00 PM
Legault Pierre Director Dec 20, 2021 Sale $57.02 7,603 433,523 0 Dec 22, 2021, 09:00 PM
Legault Pierre Director Dec 22, 2021 Sale $58.01 97,860 5,676,858 0 Dec 22, 2021, 09:00 PM
Lee Kevin Chief Executive Officer Oct 18, 2021 Sale $60.00 49 2,940 225,085 Oct 18, 2021, 06:22 PM
Lee Kevin Chief Executive Officer Oct 15, 2021 Sale $60.05 320 19,216 225,134 Oct 18, 2021, 06:22 PM
Lee Kevin Chief Executive Officer Oct 14, 2021 Sale $60.00 4,631 277,860 225,454 Oct 18, 2021, 06:22 PM
Lee Kevin Chief Executive Officer Oct 11, 2021 Sale $53.88 5,000 269,388 230,683 Oct 13, 2021, 05:28 PM
Keen Nicholas Chief Scientific Officer Oct 01, 2021 Sale $45.00 1,188 53,460 2,178 Oct 05, 2021, 04:16 PM
Keen Nicholas Chief Scientific Officer Oct 05, 2021 Sale $45.10 2,178 98,228 0 Oct 05, 2021, 04:16 PM
Smethurst Dominic Chief Medical Officer Sep 23, 2021 Option Exercise $18.55 6,000 111,300 6,000 Sep 27, 2021, 04:53 PM
Keen Nicholas Chief Scientific Officer Sep 16, 2021 Sale $45.01 1,955 87,995 3,366 Sep 17, 2021, 04:47 PM
Keen Nicholas Chief Scientific Officer Sep 15, 2021 Sale $45.00 3,000 135,000 5,321 Sep 17, 2021, 04:47 PM
Kalowski Lee President and CFO Sep 02, 2021 Option Exercise $9.82 10,000 98,200 10,000 Sep 03, 2021, 04:49 PM
Kalowski Lee President and CFO Sep 02, 2021 Sale $40.00 10,000 400,000 0 Sep 03, 2021, 04:49 PM
Keen Nicholas Chief Scientific Officer Sep 02, 2021 Sale $40.00 10,000 400,000 8,321 Sep 03, 2021, 04:47 PM
Lee Kevin Chief Executive Officer Sep 01, 2021 Option Exercise $14.00 22,890 320,460 267,170 Sep 03, 2021, 04:46 PM
Lee Kevin Chief Executive Officer Sep 02, 2021 Sale $40.00 5,000 200,000 235,085 Sep 03, 2021, 04:46 PM
Lee Kevin Chief Executive Officer Sep 01, 2021 Sale $37.21 27,085 1,007,897 258,979 Sep 03, 2021, 04:46 PM
Lee Kevin Chief Executive Officer Aug 31, 2021 Option Exercise $14.00 10,420 145,880 255,505 Aug 31, 2021, 05:29 PM
Lee Kevin Chief Executive Officer Aug 27, 2021 Option Exercise $14.00 1,808 25,312 246,893 Aug 31, 2021, 05:29 PM
Lee Kevin Chief Executive Officer Aug 27, 2021 Sale $36.02 1,808 65,124 245,085 Aug 31, 2021, 05:29 PM
Lee Kevin Chief Executive Officer Aug 31, 2021 Sale $36.33 11,225 407,763 245,552 Aug 31, 2021, 05:29 PM
Kalowski Lee President and CFO Aug 26, 2021 Option Exercise $8.76 550 4,818 550 Aug 27, 2021, 06:31 PM
Kalowski Lee President and CFO Aug 27, 2021 Option Exercise $8.73 7,950 69,403 7,950 Aug 27, 2021, 06:31 PM
Kalowski Lee President and CFO Aug 26, 2021 Sale $35.04 550 19,272 0 Aug 27, 2021, 06:31 PM
Kalowski Lee President and CFO Aug 27, 2021 Sale $35.15 7,950 279,443 0 Aug 27, 2021, 06:31 PM
Kalowski Lee President and CFO Aug 23, 2021 Option Exercise $1.60 7,500 12,000 7,500 Aug 25, 2021, 05:45 PM
Kalowski Lee President and CFO Aug 23, 2021 Sale $33.02 7,500 247,650 0 Aug 25, 2021, 05:45 PM
Kalowski Lee President and CFO Jul 29, 2021 Option Exercise $1.63 12,500 20,375 12,500 Jul 30, 2021, 06:21 PM
Kalowski Lee President and CFO Jul 29, 2021 Sale $31.51 12,500 393,823 3,504 Jul 30, 2021, 06:21 PM
Lee Kevin Chief Executive Officer Jul 26, 2021 Option Exercise $14.00 100 1,400 245,185 Jul 27, 2021, 07:08 PM
Lee Kevin Chief Executive Officer Jul 23, 2021 Option Exercise $14.00 4,782 66,948 249,867 Jul 27, 2021, 07:08 PM
Lee Kevin Chief Executive Officer Jul 26, 2021 Sale $36.00 100 3,600 245,085 Jul 27, 2021, 07:08 PM
Lee Kevin Chief Executive Officer Jul 23, 2021 Sale $36.02 4,782 172,248 245,085 Jul 27, 2021, 07:08 PM
BINGHAM KATE Director Jul 13, 2021 Sale $33.50 12 402 39,625 Jul 20, 2021, 04:17 PM
BINGHAM KATE Director Jul 14, 2021 Sale $34.01 43,378 1,475,182 1,831,671 Jul 20, 2021, 04:17 PM
BINGHAM KATE Director Jul 13, 2021 Sale $33.50 588 19,698 1,875,049 Jul 20, 2021, 04:17 PM
BINGHAM KATE Director Jul 14, 2021 Sale $34.01 917 31,185 38,708 Jul 20, 2021, 04:17 PM
Keen Nicholas Chief Scientific Officer Jul 14, 2021 Sale $35.00 10,000 350,000 18,321 Jul 16, 2021, 06:27 PM
Lee Kevin Chief Executive Officer Jul 16, 2021 Option Exercise $14.00 609 8,526 245,694 Jul 16, 2021, 06:27 PM
Lee Kevin Chief Executive Officer Jul 15, 2021 Option Exercise $14.00 21,970 307,580 267,055 Jul 16, 2021, 06:27 PM
Lee Kevin Chief Executive Officer Jul 15, 2021 Sale $34.28 21,970 753,132 245,085 Jul 16, 2021, 06:27 PM
Lee Kevin Chief Executive Officer Jul 16, 2021 Sale $34.00 609 20,706 245,085 Jul 16, 2021, 06:27 PM
BINGHAM KATE Director Jul 14, 2021 Sale $34.01 43,378 1,475,182 1,831,671 Jul 15, 2021, 07:03 PM
BINGHAM KATE Director Jul 13, 2021 Sale $33.50 588 19,698 1,875,049 Jul 15, 2021, 07:03 PM
BINGHAM KATE Director Jul 14, 2021 Sale $34.01 917 31,185 38,708 Jul 15, 2021, 07:03 PM
BINGHAM KATE Director Jul 13, 2021 Sale $33.50 12 402 39,625 Jul 15, 2021, 07:03 PM
Crockett Nigel Chief Business Officer Jul 13, 2021 Option Exercise $11.84 72,701 860,433 72,701 Jul 14, 2021, 06:47 PM
Crockett Nigel Chief Business Officer Jul 12, 2021 Option Exercise $11.72 7,028 82,380 7,028 Jul 14, 2021, 06:47 PM
Crockett Nigel Chief Business Officer Jul 13, 2021 Sale $32.44 72,701 2,358,362 3,121 Jul 14, 2021, 06:47 PM
Crockett Nigel Chief Business Officer Jul 12, 2021 Sale $32.03 7,028 225,107 0 Jul 14, 2021, 06:47 PM
Lee Kevin Chief Executive Officer Jul 12, 2021 Option Exercise $14.00 1,936 27,104 256,670 Jul 14, 2021, 06:47 PM
Lee Kevin Chief Executive Officer Jul 14, 2021 Option Exercise $14.00 8,331 116,634 259,550 Jul 14, 2021, 06:47 PM
Lee Kevin Chief Executive Officer Jul 13, 2021 Option Exercise $14.00 35,446 496,244 290,180 Jul 14, 2021, 06:47 PM
Lee Kevin Chief Executive Officer Jul 14, 2021 Sale $34.34 14,465 496,726 256,908 Jul 14, 2021, 06:47 PM
Lee Kevin Chief Executive Officer Jul 13, 2021 Sale $32.97 38,961 1,284,680 268,201 Jul 14, 2021, 06:47 PM
Lee Kevin Chief Executive Officer Jul 12, 2021 Sale $32.04 1,936 62,029 254,734 Jul 14, 2021, 06:47 PM
Crockett Nigel Chief Business Officer Jul 06, 2021 Option Exercise $9.82 271 2,661 271 Jul 08, 2021, 05:22 PM
Crockett Nigel Chief Business Officer Jul 06, 2021 Sale $32.00 271 8,672 0 Jul 08, 2021, 05:22 PM
Lee Kevin Chief Executive Officer May 06, 2021 Option Exercise $14.00 1,716 24,024 256,450 May 10, 2021, 05:43 PM
Lee Kevin Chief Executive Officer May 07, 2021 Option Exercise $14.00 5,604 78,456 260,338 May 10, 2021, 05:43 PM
Lee Kevin Chief Executive Officer May 06, 2021 Sale $32.14 1,716 55,152 254,734 May 10, 2021, 05:43 PM
Lee Kevin Chief Executive Officer May 07, 2021 Sale $32.23 5,604 180,617 254,734 May 10, 2021, 05:43 PM
Lee Kevin Chief Executive Officer Apr 27, 2021 Option Exercise $14.00 6,636 92,904 261,370 Apr 28, 2021, 04:45 PM
Lee Kevin Chief Executive Officer Apr 26, 2021 Option Exercise $14.00 14,545 203,630 273,345 Apr 28, 2021, 04:45 PM
Lee Kevin Chief Executive Officer Apr 27, 2021 Sale $30.70 6,636 203,728 255,092 Apr 28, 2021, 04:45 PM
Lee Kevin Chief Executive Officer Apr 26, 2021 Sale $31.28 18,611 582,144 268,630 Apr 28, 2021, 04:45 PM
Legault Pierre Director Apr 08, 2021 Option Exercise $8.74 24,838 217,084 24,838 Apr 09, 2021, 04:36 PM
Legault Pierre Director Apr 08, 2021 Sale $31.71 24,838 787,588 12,338 Apr 09, 2021, 04:36 PM
Legault Pierre Director Apr 05, 2021 Option Exercise $8.83 162 1,430 162 Apr 07, 2021, 07:22 PM
Legault Pierre Director Apr 05, 2021 Sale $31.07 162 5,033 0 Apr 07, 2021, 07:22 PM
Keen Nicholas Chief Scientific Officer Mar 31, 2021 Sale $30.00 10,000 300,000 28,321 Apr 02, 2021, 04:45 PM
Legault Pierre Director Mar 31, 2021 Option Exercise $8.78 10,000 87,800 10,000 Apr 02, 2021, 04:44 PM
Legault Pierre Director Mar 31, 2021 Sale $30.00 10,000 300,000 0 Apr 02, 2021, 04:44 PM
Legault Pierre Director Mar 17, 2021 Option Exercise $8.85 7,784 68,888 7,784 Mar 19, 2021, 04:48 PM
Legault Pierre Director Mar 17, 2021 Sale $29.00 7,784 225,736 0 Mar 19, 2021, 04:48 PM
Legault Pierre Director Mar 12, 2021 Option Exercise $8.86 2,216 19,634 2,216 Mar 16, 2021, 07:42 PM
Legault Pierre Director Mar 12, 2021 Sale $29.00 2,216 64,264 0 Mar 16, 2021, 07:42 PM
Keen Nicholas Chief Scientific Officer Mar 15, 2021 Sale $28.00 217 6,076 38,321 Mar 16, 2021, 07:41 PM
Keen Nicholas Chief Scientific Officer Mar 12, 2021 Sale $28.50 9,783 278,767 38,821 Mar 16, 2021, 07:41 PM
Lee Kevin Chief Executive Officer Feb 05, 2021 Sale $31.00 100 3,100 258,800 Feb 09, 2021, 05:28 PM
Lee Kevin Chief Executive Officer Jan 20, 2021 Sale $31.88 1,185 37,779 259,351 Jan 21, 2021, 04:34 PM
Lee Kevin Chief Executive Officer Jan 19, 2021 Sale $29.26 5,000 146,290 260,556 Jan 21, 2021, 04:34 PM
Kalowski Lee President and CFO Jan 19, 2021 Option Exercise $1.59 15,000 23,850 15,000 Jan 21, 2021, 04:29 PM
Kalowski Lee President and CFO Jan 19, 2021 Sale $30.00 15,000 450,000 0 Jan 21, 2021, 04:29 PM
Kalowski Lee President and CFO Jan 14, 2021 Option Exercise $1.60 10,000 16,000 10,000 Jan 15, 2021, 04:44 PM
Kalowski Lee President and CFO Jan 14, 2021 Sale $25.00 10,000 250,000 0 Jan 15, 2021, 04:44 PM
Lee Kevin Chief Executive Officer Jan 14, 2021 Sale $25.00 5,000 125,000 270,085 Jan 15, 2021, 04:40 PM
Lee Kevin Chief Executive Officer Jan 15, 2021 Sale $27.01 5,000 135,050 265,085 Jan 15, 2021, 04:40 PM
Kalowski Lee President and CFO Dec 01, 2020 Option Exercise $1.56 7,500 11,700 7,500 Dec 03, 2020, 08:53 PM
Kalowski Lee President and CFO Dec 01, 2020 Sale $22.50 7,500 168,750 0 Dec 03, 2020, 08:53 PM
Kalowski Lee President and CFO Nov 27, 2020 Option Exercise $1.56 530 827 530 Nov 30, 2020, 04:42 PM
Kalowski Lee President and CFO Nov 27, 2020 Sale $20.00 530 10,600 0 Nov 30, 2020, 04:42 PM
Kalowski Lee President and CFO Nov 25, 2020 Option Exercise $1.56 9,781 15,258 9,781 Nov 25, 2020, 08:31 PM
Kalowski Lee President and CFO Nov 23, 2020 Option Exercise $1.56 17,189 26,815 17,189 Nov 25, 2020, 08:31 PM
Kalowski Lee President and CFO Nov 25, 2020 Sale $20.07 9,781 196,305 0 Nov 25, 2020, 08:31 PM
Kalowski Lee President and CFO Nov 23, 2020 Sale $19.83 17,189 340,805 213 Nov 25, 2020, 08:31 PM
GLAXOSMITHKLINE PLC 10% Owner Jul 15, 2020 Sale $19.40 3,147 61,045 1,910,609 Sep 18, 2020, 12:04 PM
GLAXOSMITHKLINE PLC 10% Owner Jul 14, 2020 Sale $19.27 1,597 30,781 1,913,678 Sep 18, 2020, 12:04 PM
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% Owner May 28, 2019 Buy $14.00 364,286 5,100,004 1,957,961 Jun 03, 2019, 05:15 PM
Cambridge Innovation Capital (Jersey) Ltd 10% Owner May 29, 2019 Buy $14.00 314,286 4,400,004 1,751,437 May 31, 2019, 05:12 PM
Novartis Bioventures Ltd 10% Owner May 28, 2019 Buy $14.00 168,630 2,360,820 1,769,641 May 30, 2019, 09:27 PM
NG CAROLYN Director May 27, 2019 Buy $14.00 571,429 8,000,006 571,429 May 30, 2019, 09:27 PM
SVLSF V, LLC 10% Owner May 28, 2019 Buy $14.00 7,983 111,762 39,637 May 30, 2019, 09:26 PM
SVLSF V, LLC 10% Owner May 28, 2019 Buy $14.00 377,732 5,288,248 1,875,637 May 30, 2019, 09:26 PM
Anstey Michael Director May 28, 2019 Buy $14.00 314,286 4,400,004 1,751,437 May 30, 2019, 09:26 PM
BINGHAM KATE Director May 28, 2019 Buy $14.00 7,983 111,762 39,637 May 30, 2019, 09:26 PM
BINGHAM KATE Director May 28, 2019 Buy $14.00 377,732 5,288,248 1,875,637 May 30, 2019, 09:26 PM
HARLAND DEBORAH Director May 28, 2019 Buy $14.00 385,714 5,399,996 1,915,275 May 30, 2019, 09:25 PM
GLAXOSMITHKLINE PLC Director May 28, 2019 Buy $14.00 385,714 5,399,996 1,915,275 May 30, 2019, 05:47 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Milnes Alistair Chief Operating Officer 03/25/2022 103,719
Keen Nicholas Chief Scientific Officer 12/21/2021 216,678
Legault Pierre Director 12/22/2021 829,853
Legault Pierre Director 12/21/2021 375,892
Legault Pierre Director 12/20/2021 63,941
Legault Pierre Director 12/21/2021 2,543,508
Legault Pierre Director 12/20/2021 433,523
Legault Pierre Director 12/22/2021 5,676,858
Lee Kevin Chief Executive Officer 10/18/2021 2,940
Lee Kevin Chief Executive Officer 10/15/2021 19,216
Lee Kevin Chief Executive Officer 10/14/2021 277,860
Lee Kevin Chief Executive Officer 10/11/2021 269,388
Keen Nicholas Chief Scientific Officer 10/01/2021 53,460
Keen Nicholas Chief Scientific Officer 10/05/2021 98,228
Smethurst Dominic Chief Medical Officer 09/23/2021 111,300
Keen Nicholas Chief Scientific Officer 09/16/2021 87,995
Keen Nicholas Chief Scientific Officer 09/15/2021 135,000
Kalowski Lee President and CFO 09/02/2021 98,200
Kalowski Lee President and CFO 09/02/2021 400,000
Keen Nicholas Chief Scientific Officer 09/02/2021 400,000
Lee Kevin Chief Executive Officer 09/01/2021 320,460
Lee Kevin Chief Executive Officer 09/02/2021 200,000
Lee Kevin Chief Executive Officer 09/01/2021 1,007,897
Lee Kevin Chief Executive Officer 08/31/2021 145,880
Lee Kevin Chief Executive Officer 08/27/2021 25,312
Lee Kevin Chief Executive Officer 08/27/2021 65,124
Lee Kevin Chief Executive Officer 08/31/2021 407,763
Kalowski Lee President and CFO 08/26/2021 4,818
Kalowski Lee President and CFO 08/27/2021 69,403
Kalowski Lee President and CFO 08/26/2021 19,272
Kalowski Lee President and CFO 08/27/2021 279,443
Kalowski Lee President and CFO 08/23/2021 12,000
Kalowski Lee President and CFO 08/23/2021 247,650
Kalowski Lee President and CFO 07/29/2021 20,375
Kalowski Lee President and CFO 07/29/2021 393,823
Lee Kevin Chief Executive Officer 07/26/2021 1,400
Lee Kevin Chief Executive Officer 07/23/2021 66,948
Lee Kevin Chief Executive Officer 07/26/2021 3,600
Lee Kevin Chief Executive Officer 07/23/2021 172,248
BINGHAM KATE Director 07/13/2021 402
BINGHAM KATE Director 07/14/2021 1,475,182
BINGHAM KATE Director 07/13/2021 19,698
BINGHAM KATE Director 07/14/2021 31,185
Keen Nicholas Chief Scientific Officer 07/14/2021 350,000
Lee Kevin Chief Executive Officer 07/16/2021 8,526
Lee Kevin Chief Executive Officer 07/15/2021 307,580
Lee Kevin Chief Executive Officer 07/15/2021 753,132
Lee Kevin Chief Executive Officer 07/16/2021 20,706
BINGHAM KATE Director 07/14/2021 1,475,182
BINGHAM KATE Director 07/13/2021 19,698
BINGHAM KATE Director 07/14/2021 31,185
BINGHAM KATE Director 07/13/2021 402
Crockett Nigel Chief Business Officer 07/13/2021 860,433
Crockett Nigel Chief Business Officer 07/12/2021 82,380
Crockett Nigel Chief Business Officer 07/13/2021 2,358,362
Crockett Nigel Chief Business Officer 07/12/2021 225,107
Lee Kevin Chief Executive Officer 07/12/2021 27,104
Lee Kevin Chief Executive Officer 07/14/2021 116,634
Lee Kevin Chief Executive Officer 07/13/2021 496,244
Lee Kevin Chief Executive Officer 07/14/2021 496,726
Lee Kevin Chief Executive Officer 07/13/2021 1,284,680
Lee Kevin Chief Executive Officer 07/12/2021 62,029
Crockett Nigel Chief Business Officer 07/06/2021 2,661
Crockett Nigel Chief Business Officer 07/06/2021 8,672
Lee Kevin Chief Executive Officer 05/06/2021 24,024
Lee Kevin Chief Executive Officer 05/07/2021 78,456
Lee Kevin Chief Executive Officer 05/06/2021 55,152
Lee Kevin Chief Executive Officer 05/07/2021 180,617
Lee Kevin Chief Executive Officer 04/27/2021 92,904
Lee Kevin Chief Executive Officer 04/26/2021 203,630
Lee Kevin Chief Executive Officer 04/27/2021 203,728
Lee Kevin Chief Executive Officer 04/26/2021 582,144
Legault Pierre Director 04/08/2021 217,084
Legault Pierre Director 04/08/2021 787,588
Legault Pierre Director 04/05/2021 1,430
Legault Pierre Director 04/05/2021 5,033
Keen Nicholas Chief Scientific Officer 03/31/2021 300,000
Legault Pierre Director 03/31/2021 87,800
Legault Pierre Director 03/31/2021 300,000
Legault Pierre Director 03/17/2021 68,888
Legault Pierre Director 03/17/2021 225,736
Legault Pierre Director 03/12/2021 19,634
Legault Pierre Director 03/12/2021 64,264
Keen Nicholas Chief Scientific Officer 03/15/2021 6,076
Keen Nicholas Chief Scientific Officer 03/12/2021 278,767
Lee Kevin Chief Executive Officer 02/05/2021 3,100
Lee Kevin Chief Executive Officer 01/20/2021 37,779
Lee Kevin Chief Executive Officer 01/19/2021 146,290
Kalowski Lee President and CFO 01/19/2021 23,850
Kalowski Lee President and CFO 01/19/2021 450,000
Kalowski Lee President and CFO 01/14/2021 16,000
Kalowski Lee President and CFO 01/14/2021 250,000
Lee Kevin Chief Executive Officer 01/14/2021 125,000
Lee Kevin Chief Executive Officer 01/15/2021 135,050
Kalowski Lee President and CFO 12/01/2020 11,700
Kalowski Lee President and CFO 12/01/2020 168,750
Kalowski Lee President and CFO 11/27/2020 827
Kalowski Lee President and CFO 11/27/2020 10,600
Kalowski Lee President and CFO 11/25/2020 15,258
Kalowski Lee President and CFO 11/23/2020 26,815
Kalowski Lee President and CFO 11/25/2020 196,305
Kalowski Lee President and CFO 11/23/2020 340,805
GLAXOSMITHKLINE PLC 10% Owner 07/15/2020 61,045
GLAXOSMITHKLINE PLC 10% Owner 07/14/2020 30,781
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% Owner 05/28/2019 5,100,004
Cambridge Innovation Capital (Jersey) Ltd 10% Owner 05/29/2019 4,400,004
Novartis Bioventures Ltd 10% Owner 05/28/2019 2,360,820
NG CAROLYN Director 05/27/2019 8,000,006
SVLSF V, LLC 10% Owner 05/28/2019 111,762
SVLSF V, LLC 10% Owner 05/28/2019 5,288,248
Anstey Michael Director 05/28/2019 4,400,004
BINGHAM KATE Director 05/28/2019 111,762
BINGHAM KATE Director 05/28/2019 5,288,248
HARLAND DEBORAH Director 05/28/2019 5,399,996
GLAXOSMITHKLINE PLC Director 05/28/2019 5,399,996
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
12/31/2021
18.13%
1Q
03/31/2022
09/30/2021
24.82%
2Q
03/31/2022
06/30/2021
28.45%
3Q
03/31/2022
03/31/2021
33.95%
4Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
18.13%
1Q
09/30/2021
24.82%
2Q
06/30/2021
28.45%
3Q
03/31/2021
33.95%
4Q
Load More